Cargando…

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock

Mechanical circulatory support (MCS) devices are effective tools in managing refractory cardiogenic shock (CS). Data comparing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and IMPELLA(®) are however scarce. We aimed to assess outcomes of patients implanted with these two devices and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schurtz, Guillaume, Rousse, Natacha, Saura, Ouriel, Balmette, Vincent, Vincent, Flavien, Lamblin, Nicolas, Porouchani, Sina, Verdier, Basile, Puymirat, Etienne, Robin, Emmanuel, Van Belle, Eric, Vincentelli, André, Aissaoui, Nadia, Delhaye, Cédric, Delmas, Clément, Cosenza, Alessandro, Bonello, Laurent, Juthier, Francis, Moussa, Mouhamed Djahoum, Lemesle, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918655/ https://www.ncbi.nlm.nih.gov/pubmed/33672792 http://dx.doi.org/10.3390/jcm10040759

Ejemplares similares

Hemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology
por: Gaubert, Mélanie, et al.
Publicado: (2020)

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up
por: Bonello, Laurent, et al.
Publicado: (2019)

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
por: Schurtz, Guillaume, et al.
Publicado: (2023)

Impact of Pre-Existing History of Heart Failure on Patient Profile, Therapeutic Management, and Prognosis in Cardiogenic Shock: Insights from the FRENSHOCK Registry
por: Schurtz, Guillaume, et al.
Publicado: (2022)

Ultrasound Guidance to Reduce Vascular and Bleeding Complications of Percutaneous Transfemoral Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Comparison
por: Vincent, Flavien, et al.
Publicado: (2020)

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2022)

Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry
por: Delmas, Clement, et al.
Publicado: (2021)

One-year outcomes in cardiogenic shock triggered by ventricular arrhythmia: An analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023)

One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023)

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort
por: Van Belle, Eric, et al.
Publicado: (2022)

Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2021)

Mottling as a prognosis marker in cardiogenic shock
por: Merdji, Hamid, et al.
Publicado: (2023)

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
por: Schurtz, Guillaume, et al.
Publicado: (2014)

Weaning from Impella and mobilization of Impella patients
por: Bertoldi, Letizia Fausta, et al.
Publicado: (2021)

Comments on ‘Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure’: the bitter truth about unfractionated heparin monitoring assays
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2021)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
por: Delmas, Clément, et al.
Publicado: (2022)

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France
por: Le Guyader, Alexandre, et al.
Publicado: (2021)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Subacute right heart failure revealing three simultaneous causes of post‐embolic pulmonary hypertension in metastatic dissemination of breast cancer
por: Vincent, Flavien, et al.
Publicado: (2016)

Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry
por: Lemesle, Gilles, et al.
Publicado: (2020)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care
por: Koutsoukis, Athanasios, et al.
Publicado: (2020)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vpcc4njjg6fbjfdrdc5u9am6k